Blue Owl Capital OWL Q1 2026 Earnings EPS Surpasses Estimates Signaling Steady Momentum ESAB Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds ELTX Q1 2026 Earnings Widerthanexpected loss as clinicalstage biotech advances pipeline IMMR Q3 2025 Earnings Strong EPS Beat Driven by Licensing and Royalty Revenue BWEN Q1 2026 Earnings Strong EPS Beat Amid Revenue Uncertainty Shares Decline AXON Q1 2026 Earnings EPS Miss Slightly Stock Edges Higher